Migdal Insurance & Financial Holdings’s Syneron Medical Ltd ELOS Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-878,350	Closed	-$9.62M	–	600
2017 Q2	$9.62M	Hold	878,350	–	–	0.22%	86
2017 Q1	$9.27M	Hold	878,350	–	–	0.22%	87
2016 Q4	$7.38M	Hold	878,350	–	–	0.19%	79
2016 Q3	$6.29M	Hold	878,350	–	–	0.18%	70
2016 Q2	$6.75M	Buy	+878,350	New	+$6.26M	0.19%	71

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Migdal Insurance & Financial Holdings's ELOS Position: Q3 2017 in Review

Migdal Insurance & Financial Holdings sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 878,350 shares — an estimated $9.62M sold.

Migdal Insurance & Financial Holdings first reported a position in ELOS in Q2 2016 and held it in 5 quarters. The position peaked at $9.62M in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

Migdal Insurance & Financial Holdings reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 878,350 Syneron Medical Ltd shares in Q3 2017, an estimated $9.62M.
Migdal Insurance & Financial Holdings first reported a position in Syneron Medical Ltd in Q2 2016 and held it in 5 quarters.
Migdal Insurance & Financial Holdings's Syneron Medical Ltd position peaked at $9.62M in Q2 2017.
4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q3 2017, filed 6 Nov 2017.